Veterinary Medicines

Zitac vet 200 mg tablet for dogs

Authorised
  • Cimetidine
Download as PDF

Product identification

Medicine name:
Zitac vet 200 mg tablet for dogs
Zitac vet 200 mg tabletta kutyák részére A.U.V.
Active substance:
  • Cimetidine
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Cimetidine
    200.00
    milligram(s)
    /
    1.00
    Piece
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA02BA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Package description:
  • Carton box containing 100 tablets - 10 blister (white opaque PVC, Aluminium foil) with 10 tablets per blister
  • Carton box containing 30 tablets - 3 blister (white opaque PVC, Aluminium foil) with 10 tablets per blister

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet Ges.m.b.H.
Responsible authority:
  • National Food Chain Safety Office
Authorisation number:
  • 2102/X/06 ÁOGYTI
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0119/003
Concerned member states:
  • Czechia
  • Denmark
  • Finland
  • France
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Portugal
  • Slovenia
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."